- Home
- CRVS vs SBET Comparison
CRVS vs SBET Comparison
Compare CRVS & SBET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRVS | SBET |
|---|---|---|
| Founded | 2014 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.9B |
| IPO Year | 2016 | 1997 |
Fundamental Metrics
Financial Performance| Metric | CRVS | SBET |
|---|---|---|
| Price | $18.76 | $6.54 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $28.00 | $24.80 |
| AVG Volume (30 Days) | 7.7M | ★ 8.1M |
| Earning Date | 03-24-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $13,106,030.00 |
| Revenue This Year | N/A | $26,752.44 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 239.01 |
| 52 Week Low | $2.54 | $2.26 |
| 52 Week High | $26.95 | $124.12 |
Technical Indicators
Market Signals| Indicator | CRVS | SBET |
|---|---|---|
| Relative Strength Index (RSI) | 57.79 | 32.29 |
| Support Level | $18.50 | $6.02 |
| Resistance Level | $21.57 | $7.32 |
| Average True Range (ATR) | 1.69 | 0.56 |
| MACD | -0.59 | -0.20 |
| Stochastic Oscillator | 10.48 | 13.96 |
Price Performance
Historical ComparisonAbout CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About SBET SharpLink Gaming Ltd.
SharpLink Gaming Inc is one of the world's largest publicly traded companies to adopt ETH as its primary treasury reserve asset - a move that aligns the Company with the future of digital capital and gives investors direct exposure to Ethereum, the world's smart-contract platform and second largest digital asset.